Metastatic melanoma mimicking acute leukaemia
Adult lymphoblastic leukaemia presenting with nephromegaly
Does prolonged storage of red blood cells cause harm?
Prognostic factors for acute myeloid leukaemia in adults – biological significance and clinical use
Clinical epidemiology and treatment patterns of patients with multicentric Castleman disease: results from two US treatment centres
Bone marrow hypocellularity does not affect tolerance or efficacy of azacitidine in patients with higher-risk myelodysplastic syndromes
Bioenergetic modulation overcomes glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia
Incidence of marginal zone lymphoma in the United States, 2001–2009 with a focus on primary anatomic site
The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL cells in vitro , as a single agent and in combination with other drugs
PI3KCA plays a major role in multiple myeloma and its inhibition with BYL719 decreases proliferation, synergizes with other therapies and overcomes stroma-induced resistance
Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002
The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma
Clinical analysis and prognostic significance of haemophagocytic lymphohistiocytosis-associated anaplastic large cell lymphoma in children
Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol
CD137 ligand signalling induces differentiation of primary acute myeloid leukaemia cells
Could treatment with R-HCVAD/R-MA as compared to R-CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma?
Could treatment with R-HCVAD/R-MA as compared to R- CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma? – Response to Landsburg et al
Who is an “older” patient with acute myeloid leukaemia (AML)? An investigation of two NCRI/AML trials
Milatuzumab and veltuzumab induce apoptosis through JNK signalling in an NF-κB dependent human transformed follicular lymphoma cell line
Single-nucleotide variations defining previously unreported ADAMTS13 haplotypes are associated with differential expression and activity of the VWF-cleaving protease in a Salvadoran congenital thrombotic thrombocytopenic purpura family
Clinical and Laboratory Haemostasis 2014 4–5 June 2014, Sheffield Hallam University, Sheffield, UK